Related Experiment Video
Updated: Jan 7, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
Clinical Manifestations
Brandon E Gavett1, Evan Fletcher2, Sarah Tomaszewski Farias3
1University of California Davis, Sacramento, CA, USA.
Background:
Individual differences have been observed in the association between neurodegenerative brain changes and rates of cognitive decline. People who experience less rapid decline than expected based on neurodegeneration are described as being cognitively resilient to brain aging. We hypothesized that patterns of cognitive strengths and weaknesses (certain cognitive profiles) can provide a valid phenotype of prospective resilience.
Method:
Participants (N = 2432) were from the Alzheimer's Disease Neuroimaging Initiative (ADNI) study (1/2/3/GO). There were three analytic phases: 1) generate an estimate of prospective resilience; 2) use that resilience estimate to develop a baseline cognitive resilience phenotype; 3) validate the phenotype longitudinally. In the first phase, prospective resilience was defined as the discrepancy between rates of future cognitive and brain change (cognitive slope minus brain slope). In the second phase, a bifactor confirmatory factor analysis model defined the cognitive resilience phenotype as a latent variable representing the variance that the observed cognitive test scores shared with the prospective resilience estimate from phase 1. In the third phase, we used regression in a held-out sample to test the hypothesized interaction between the resilience phenotype and brain volume change when predicting longitudinal cognitive decline (i.e., does the phenotype modify the association between brain atrophy and rate of cognitive decline?).
Result:
The cognitive performance indicators that most strongly contributed to the resilience phenotype were Trail Making Test B (loading = .73), animal fluency (loading = .67), and Boston Naming Test (loading = .67; Table 1). The cognitive resilience phenotype moderated the regression of cognitive slope on brain slope in the held-out sample (B=-0.043, SE=0.016; Table 2, Figure 1).
Conclusion:
A cross-sectional estimate of prospective cognitive resilience against brain atrophy can be constructed from the ADNI neuropsychological test battery. This phenotype, which draws heavily upon measures of processing speed/executive functioning, category fluency, verbal naming, and immediate recall, can predict the extent to which future brain atrophy will impact rates of cognitive decline. Examining cognitive phenotypes associated with more resilient cognitive aging may help to understand neural systems that underpin resilience, potentially leading to resilience-promoting interventions and new opportunities to efficiently monitor changes in resilience over time.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Coronary Artery Disease III: Clinical Manifestations
Endocarditis II: Clinical Features of Infective Endocarditis
Heart Failure III: Clinical Manifestations
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Hypertension III: Clinical Manifestations and Diagnostic Studies

